BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 8880099)

  • 21. Differential expression of the intercellular adhesion molecule-1 (ICAM-1) in lung cancer cell lines of various histological types.
    Schardt C; Heymanns J; Schardt C; Rotsch M; Havemann K
    Eur J Cancer; 1993; 29A(16):2250-5. PubMed ID: 8110495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GM-CSF enhances IL-2-activated natural killer cell lysis of clonogenic AML cells by upregulating target cell expression of ICAM-1.
    Bendall LJ; Kortlepel K; Gottlieb DJ
    Leukemia; 1995 Apr; 9(4):677-84. PubMed ID: 7723403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon gamma enhances lymphokine-activated killer cell adhesion but not lysis of head and neck squamous cell carcinoma.
    Scher RL; Carras A; Schwab D; Richtsmeier WJ; Koch WM
    Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1271-5. PubMed ID: 7576474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of LFA-3, ICAM-1, and MHC class I on the sensitivity of human tumor cells to LAK cells.
    Gwin JL; Gercel-Taylor C; Taylor DD; Eisenberg B
    J Surg Res; 1996 Jan; 60(1):129-36. PubMed ID: 8592403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased ICAM-1 expression in transformed human oral epithelial cells: molecular mechanism and functional role in peripheral blood mononuclear cell adhesion and lymphokine-activated-killer cell cytotoxicity.
    Huang GT; Zhang X; Park NH
    Int J Oncol; 2000 Sep; 17(3):479-86. PubMed ID: 10938387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulation of intercellular adhesion molecule 1 (ICAM-1) on human renal cell carcinoma cells by interleukin-4.
    Obiri NI; Tandon N; Puri RK
    Int J Cancer; 1995 May; 61(5):635-42. PubMed ID: 7768636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiation of long-term-cultured lymphokine-activated killer cell cytotoxicity against small-cell lung carcinoma by anti-CD3 x anti-(tumor-associated antigen) bispecific antibody.
    Azuma A; Yagita H; Okumura K; Kudoh S; Niitani H
    Cancer Immunol Immunother; 1994 May; 38(5):294-8. PubMed ID: 7909278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Various cytokines modulate ICAM-1 shedding on melanoma- and CTCL-derived cell lines: inverse regulation of ICAM-1 shedding in a Sézary cell line by interferon-gamma.
    Dummer R; Sigg-Zemann S; Kalthof K; Muletta S; Meyer JC; Burg G
    Dermatology; 1994; 189(2):120-4. PubMed ID: 7915555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfection-induced tumor necrosis factor-alpha increases the susceptibility of human glioma cells to lysis by lymphokine-activated killer cells: continuous expression of intercellular adhesion molecule-1 on the glioma cells.
    Takaoka T; Yoshida J; Mizuno M; Sugita K
    Jpn J Cancer Res; 1994 Jul; 85(7):750-5. PubMed ID: 7915264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of interferon-gamma and tumor necrosis factor-alpha on the expression of ICAM-1 and HLA-DR molecules on cells of a human germ cell neoplasm and their susceptibility to lysis by lymphokine-activated killer cells.
    Eisenthal A; Marder O; Maymon B; Misonzhnik F; Skornick Y; Brazowski E; Czernobilsky B; Walt H; Lifschitz-Mercer B
    Pathobiology; 1998; 66(5):205-8. PubMed ID: 9732234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-gamma-induced increased sensitivity of HER2/neu-overexpressing tumor cells to lymphokine-activated killer cell lysis: importance of ICAM-1 in binding and post-binding events.
    Fady C; Gardner A; Gera JF; Lichtenstein A
    Cancer Immunol Immunother; 1993 Oct; 37(5):329-36. PubMed ID: 8104695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TNF-alpha and IFN-gamma reverse IL-4 inhibition of lymphokine-activated killer cell function.
    Swisher SG; Economou JS; Holmes EC; Golub SH
    Cell Immunol; 1990 Jul; 128(2):450-61. PubMed ID: 2113430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of a small cell lung cancer variant resistant to lymphokine-activated killer (LAK) cells: association with resistance to a LAK cell-derived, cytostatic factor.
    Tachibana I; Watanabe M; Tanio Y; Hayashi S; Hosoe S; Saito S; Matsunashi M; Osaki T; Shigedo Y; Masuno T
    Cancer Res; 1992 Jun; 52(12):3310-6. PubMed ID: 1350752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of granulocyte-macrophage colony-stimulating factor on lymphokine-activated killer cell induction.
    Stewart-Akers AM; Cairns JS; Tweardy DJ; McCarthy SA
    Blood; 1993 May; 81(10):2671-8. PubMed ID: 8490177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The enhancement of cytolytic activity in lymphokine activated killer cells using bispecific F(ab')2].
    Azuma A
    Nihon Ika Daigaku Zasshi; 1991 Dec; 58(6):663-72. PubMed ID: 1663120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-2-inducible killer activity and its regulation by blood monocytes from autologous lymphocytes of lung cancer patients.
    Sone S; Kunishige E; Fawzy F; Yanagawa H; Nii A; Maeda K; Atagi S; Heike Y; Nishioka Y; Mizuno K
    Jpn J Cancer Res; 1991 Jun; 82(6):716-23. PubMed ID: 1649813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Generation of T cell-mediated antitumor response in vitro by autologous dendritic cells pulsed with tumor lysates in patients with non-small cell lung cancer].
    You J; Yu JP; Ren XB; Wang CL; Zhang P; Zhang XZ
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):333-6. PubMed ID: 15312341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pentoxifylline-induced modulation of melanoma cell growth, adhesion and lymphokine activated killer cell-mediated lysis.
    Alexander CL; Edward M; MacKie RM
    Melanoma Res; 1999 Feb; 9(1):31-9. PubMed ID: 10338332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxicity of interleukin 2-induced lymphokine-activated killer (LAK) cells against human leukemia and augmentation of killing by interferons and tumor necrosis factor.
    Teichmann JV; Ludwig WD; Thiel E
    Leuk Res; 1992; 16(3):287-98. PubMed ID: 1560676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.